FiercePharma2 天
EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...
The Massachusetts Daily Collegian4 天
Food Recovery Network continues to serve students
The FRN is one of several food justice initiatives brought onto campus in recent times. Various organizations have come ...
Cure Today5 天
Looking Ahead After Kisqali’s FDA Approval for Adjuvant Treatment of Early Breast Cancer
Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...